Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

This is a multi-center, open-label study to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary activity of REC…

UnresectableLocally AdvancedMetastatic Cancers+1 more

Recursion Pharmaceuticals Inc.NCT06678659